Search

Author/Creator Howieson, Corrie

1. Pharmacokinetic Assessment of Drug‐Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy Adults. Issue 1 (25th July 2016)

Authors:
Groll, Andreas H.; Desai, Amit; Han, David; Howieson, Corrie; Kato, Kota; Akhtar, Shahzad; Kowalski, Donna; Lademacher, Christopher; Lewis, William; Pearlman, Helene; Mandarino, Debra; Yamazaki, Takao; Townsend, Robert
Journal:
Clinical pharmacology in drug development
Issue:
Volume 6:Issue 1(2017)
Page Start:
76
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Pharmacokinetic Effects of Isavuconazole Coadministration With the Cytochrome P450 Enzyme Substrates Bupropion, Repaglinide, Caffeine, Dextromethorphan, and Methadone in Healthy Subjects. Issue 1 (15th July 2016)

Authors:
Yamazaki, Takao; Desai, Amit; Goldwater, Ronald; Han, David; Howieson, Corrie; Akhtar, Shahzad; Kowalski, Donna; Lademacher, Christopher; Pearlman, Helene; Rammelsberg, Diane; Townsend, Robert
Journal:
Clinical pharmacology in drug development
Issue:
Volume 6:Issue 1(2017)
Page Start:
54
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Pharmacokinetic Interactions Between Isavuconazole and the Drug Transporter Substrates Atorvastatin, Digoxin, Metformin, and Methotrexate in Healthy Subjects. Issue 1 (15th July 2016)

Authors:
Yamazaki, Takao; Desai, Amit; Goldwater, Ronald; Han, David; Lasseter, Kenneth C.; Howieson, Corrie; Akhtar, Shahzad; Kowalski, Donna; Lademacher, Christopher; Rammelsberg, Diane; Townsend, Robert
Journal:
Clinical pharmacology in drug development
Issue:
Volume 6:Issue 1(2017)
Page Start:
66
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of ASP2408, a Potent Selective T‐Cell Costimulation Modulator After Single and Multiple Ascending Doses in Healthy Volunteers and RA Patients. Issue 5 (28th March 2016)

Authors:
Zhu, Tong; Keirns, James; Howieson, Corrie; Kaibara, Atsunori; Goldwater, Ronald; Kivitz, Alan J.; Chindalore, Vishala; Cohen, Stanley; Santos, Vicki; Akinlade, Bolanle; Kernstock, Robert; Delgado‐Herrera, Leticia; Blahunka, Paul C; Karrer, Erik E.; Garg, Jay P.; Samberg, Nancy; Zeiher, Bernhardt G.
Journal:
Clinical pharmacology in drug development
Issue:
Volume 5:Issue 5(2016:Sep./Oct.)
Page Start:
408
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. The Effect of Verapamil, a P‐Glycoprotein Inhibitor, on the Pharmacokinetics of Peficitinib, an Orally Administered, Once‐Daily JAK Inhibitor. Issue 6 (16th March 2017)

Authors:
Zhu, Tong; Howieson, Corrie; Wojtkowski, Tomasz; Garg, Jay P.; Han, David; Fisniku, Ogert; Keirns, James
Journal:
Clinical pharmacology in drug development
Issue:
Volume 6:Issue 6(2017)
Page Start:
548
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗